Misplaced Pages

Hypothyroidism: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 03:59, 16 June 2013 editDavidruben (talk | contribs)Extended confirmed users18,994 edits →Subclinical hypothyroidism: TSH 2.5 is not cut off for starting therapy (normal range is up to 4.95), 10 is general level above which treatment started.← Previous edit Revision as of 04:12, 16 June 2013 edit undoDavidruben (talk | contribs)Extended confirmed users18,994 editsm →Subclinical hypothyroidism: name ref for later useNext edit →
Line 100: Line 100:
Subclinical hypothyroidism occurs when thyroid stimulating hormone(TSH) levels are elevated but thyroxine (T<sub>4</sub>) and triiodothyronine (T<sub>3</sub>) levels are normal.<ref name="Auburn University">{{cite book |author=Jack DeRuiter |title=Endocrine Module (PYPP 5260) |chapter=Thyroid pathology |chapterurl=http://www.auburn.edu/~deruija/endp_thyroidpathol.pdf |format=PDF |year=2002 |page=30 |publisher=Auburn University School of Pharmacy}}</ref> In primary hypothyroidism, TSH levels are high and T<sub>4</sub> and T<sub>3</sub> levels are low. TSH usually increases when T<sub>4</sub> and T<sub>3</sub> levels drop. TSH prompts the thyroid gland to make more hormone. In subclinical hypothyroidism, TSH is elevated but below the limit representing overt hypothyroidism. The levels of the active hormones will be within the laboratory reference ranges. Subclinical hypothyroidism occurs when thyroid stimulating hormone(TSH) levels are elevated but thyroxine (T<sub>4</sub>) and triiodothyronine (T<sub>3</sub>) levels are normal.<ref name="Auburn University">{{cite book |author=Jack DeRuiter |title=Endocrine Module (PYPP 5260) |chapter=Thyroid pathology |chapterurl=http://www.auburn.edu/~deruija/endp_thyroidpathol.pdf |format=PDF |year=2002 |page=30 |publisher=Auburn University School of Pharmacy}}</ref> In primary hypothyroidism, TSH levels are high and T<sub>4</sub> and T<sub>3</sub> levels are low. TSH usually increases when T<sub>4</sub> and T<sub>3</sub> levels drop. TSH prompts the thyroid gland to make more hormone. In subclinical hypothyroidism, TSH is elevated but below the limit representing overt hypothyroidism. The levels of the active hormones will be within the laboratory reference ranges.


Generally subclinical hypothyroidism with TSH under 10mU/l does not require treatment.<ref>{{cite web |title=The Diagnosis and Management of Primary Hypothyroidism |author=The Royal College of Physicians, The Association for Clinical Biochemistry Generally subclinical hypothyroidism with TSH under 10mU/l does not require treatment.<ref name="RCP2008">{{cite web |title=The Diagnosis and Management of Primary Hypothyroidism |author=The Royal College of Physicians, The Association for Clinical Biochemistry The Society for Endocrinology, The British Thyroid Association ''et al'' |date=19th November 2008 |url=http://www.british-thyroid-association.org/news/Docs/hypothyroidism_statement.pdf |format=pdf |accessdate = 2013-06-16}}</ref>
The Society for Endocrinology, The British Thyroid Association ''et al'' |date=19th November 2008 |url=http://www.british-thyroid-association.org/news/Docs/hypothyroidism_statement.pdf |format=pdf |accessdate = 2013-06-16}}</ref>


==Pregnancy and fertility== ==Pregnancy and fertility==

Revision as of 04:12, 16 June 2013

Medical condition
Hypothyroidism
SpecialtyEndocrinology Edit this on Wikidata

Hypothyroidism /ˌhaɪpˈθaɪərɔɪdɪzəm/ is a state in which the thyroid gland does not produce a sufficient amount of the thyroid hormones thyroxine (T4) and triiodothyronine (T3).

Iodine deficiency is often cited as the most common cause of hypothyroidism worldwide but it can be caused by many other factors. It can result from the lack of a thyroid gland or from iodine-131 treatment, and can also be associated with increased stress. Severe hypothyroidism in infants can result in cretinism.

A 2011 study concluded that about 8% of women over 50 and men over 65 in the UK suffer from an under-active thyroid and that as many as 100,000 of these people could benefit from treatment they are currently not receiving.

Classification

Hypothyroidism is often classified by association with the indicated organ dysfunction (see below):

Type Origin
Primary Thyroid gland The most common forms include Hashimoto's thyroiditis (an autoimmune disease) and radioiodine therapy for hyperthyroidism.
Secondary Pituitary gland Occurs if the pituitary gland does not create enough thyroid-stimulating hormone (TSH) to induce the thyroid gland to produce enough thyroxine and triiodothyronine. Although not every case of secondary hypothyroidism has a clear cause, it is usually caused by damage to the pituitary gland, as by a tumor, radiation, or surgery. Secondary hypothyroidism accounts for less than 5% or 10% of hypothyroidism cases.
Tertiary Hypothalamus Results when the hypothalamus fails to produce sufficient thyrotropin-releasing hormone (TRH). TRH prompts the pituitary gland to produce thyroid-stimulating hormone (TSH). Hence may also be termed hypothalamic-pituitary-axis hypothyroidism. It accounts for less than 5% of hypothyroidism cases.

Signs and symptoms

Early hypothyroidism is often asymptomatic and can have very mild symptoms. Subclinical hypothyroidism is a state of normal thyroid hormone levels, thyroxine (T4) and triiodothyronine (T3), with mild elevation of thyrotropin, thyroid-stimulating hormone (TSH). With higher TSH levels and low free T4 levels, symptoms become more readily apparent in clinical (or overt) hypothyroidism.

Hypothyroidism can be associated with the following symptoms:

Early

Late

Uncommon

Subclinical hypothyroidism

Subclinical hypothyroidism occurs when thyroid stimulating hormone(TSH) levels are elevated but thyroxine (T4) and triiodothyronine (T3) levels are normal. In primary hypothyroidism, TSH levels are high and T4 and T3 levels are low. TSH usually increases when T4 and T3 levels drop. TSH prompts the thyroid gland to make more hormone. In subclinical hypothyroidism, TSH is elevated but below the limit representing overt hypothyroidism. The levels of the active hormones will be within the laboratory reference ranges.

Generally subclinical hypothyroidism with TSH under 10mU/l does not require treatment.

Pregnancy and fertility

Main article: Thyroid disease in pregnancy

During pregnancy, there is a substantially increased need of thyroid hormones and a substantial risk that previously unnoticed subclinical or latent hypothyroidism will progress to overt hypothyroidism.

Subclinical hypothyroidism in early pregnancy, compared with normal thyroid function, has been estimated to increase the risk of pre-eclampsia with an odds ratio (OR) of 1.7 and the risk of perinatal mortality with an OR of 2.7. In subclinical hypothyroidism, supplementation with levothyroxine results in significantly higher delivery rate, with a pooled relative probability of 2.76.

Even mild or subclinical hypothyroidism is known to adversely affect fertility.

Epidemiology

Hypothyroidism is estimated to affect between 3.8-4.6% of the general population. 0.3% of the general American population have overt hypothyroidism, and 4.3% have subclinical hypothyroidism. A 1995 survey in the UK found the mean incidence (with 95% confidence intervals) of spontaneous hypothyroidism in women was 3.5/1000 survivors/year (2.8–4.5) rising to 4.1/1000 survivors/year (3.3–5.0) for all causes of hypothyroidism and in men was 0.6/1000 survivors/year (0.3–1.2). Data from the CDC spanning the years 1999 to 2010 yield similar numbers: hypothyroidism is four times as common among women as among men.

Estimates of subclinical hypothyroidism range between 3% and 8%, increasing with age; the median age of someone with hypothyroidism is 58.

Causes

Iodine deficiency is the most common cause of hypothyroidism worldwide. In iodine-replete areas of the world, hypothyroidism is most commonly caused by Hashimoto's thyroiditis, or otherwise as a result of either an absent thyroid gland or a deficiency in stimulating hormones from the hypothalamus or pituitary. Congenital hypothyroidism is a rare cause of hypothyroidism and may result from thyroid agenesis and has an incidence of approximately 1 in 4000 births.

Hypothyroidism can be caused by medications such as lithium-based mood stabilizers, a medication usually used to treat bipolar disorder. In fact, lithium has occasionally been used to treat hyperthyroidism. Other drugs that may produce hypothyroidism include amiodarone, interferon alpha, interleukin-2, rifampicin, sunitinib, and thalidomide. Temporary hypothyroidism can be due to the Wolff-Chaikoff effect. A very high intake of iodine can be used to temporarily treat hyperthyroidism, especially in an emergency situation. Although iodide is a substrate for thyroid hormones, high levels reduce iodide organification in the thyroid gland, decreasing hormone production.

Exposure to radioactive iodine-131 can induce a state of hypothyroidism and this effect is used to medically treat hyperthyroidism. De Quervain's thyroiditis, thought to be viral in origin, is a condition that can transiently cause hyperthyroidism and later progress to hypothyroidism.

Hypothyroidism can result from postpartum thyroiditis up to 9 months after giving birth, characterized by transient hyperthyroidism followed by transient hypothyroidism. The syndrome is seen in 5 to 9% of women. The first phase is typically hyperthyroidism; the thyroid then either returns to normal, or a woman develops hypothyroidism. Of those women who experience hypothyroidism associated with postpartum thyroiditis, 25 to 30% will develop permanent hypothyroidism requiring lifelong thyroxine replacement therapy.

Stress and hypothyroidism

Stress is known to be a significant contributor to thyroid dysfunction; this can be environmental stress as well as lesser-considered homeostatic stress such as fluctuating blood sugar levels and immune problems. Stress's effect on thyroid function can be indirect, through its effects on blood sugar levels (dysglycemia), but it can also have more direct effects. Stress may cause hypothyroidism or reduced thyroid functioning by disrupting the HPA axis which down-regulates thyroid function, reducing the conversion of T4 to T3, weakening the immune system thus promoting autoimmunity, causing thyroid hormone resistance, and resulting in hormonal imbalances. Indeed, excess estrogen in the blood caused by chronic cortisol elevations can result in hypothyroid symptoms by decreasing levels of active T3. Stress also affects thyroid functioning through the sympathetic nervous system. A 1994 study of refugees from East Germany who experienced chronic stress found them to have a very high rate of hypothyroidism or subclinical hypothyroidism, although not all refugees displayed clinical or behavioral symptoms associated with this reduced thyroid functioning. TSH levels correlate positively with physiological stress.

Adrenal insufficiency can also result in hypothyroid symptoms without affecting the thyroid itself.

Diagnosis

Main article: Thyroid function tests

The only validated test to diagnose primary hypothyroidism, is to measure thyroid-stimulating hormone (TSH) and free thyroxine (T4). However, these levels can be affected by non-thyroidal illnesses.

High levels of TSH indicate that the thyroid is not producing sufficient levels of thyroid hormone (mainly as thyroxine (T4) and smaller amounts of triiodothyronine (T3)). However, measuring just TSH fails to diagnose secondary and tertiary hypothyroidism, thus leading to the following suggested blood testing if the TSH is normal and hypothyroidism is still suspected:

  • Free triiodothyronine (fT3)
  • Free thyroxine (fT4)
  • Total T3
  • Total T4

Additionally, the following measurements may be needed:

  • Free T3 from 24-hour urine catch
  • Antithyroid antibodies – for evidence of autoimmune diseases that may be damaging the thyroid gland
  • Serum cholesterol – which may be elevated in hypothyroidism
  • Prolactin – as a widely available test of pituitary function
  • Testing for anemia, including ferritin
  • Basal body temperature

Treatment

Main article: Medical use of thyroid hormones

Hypothyroidism is treated with the levorotatory forms of thyroxine (levothyroxine) (L-T4) and triiodothyronine (liothyronine) (L-T3). Synthroid, produced by Abbott Laboratories, is the brand name counterpart to the generic Levothyroxine. Synthroid is also the most common pill prescribed by doctors that has the synthetic thyroid hormone in it, and it is taken by over 40% of people with hypothyroidism. This medicine can improve symptoms of thyroid deficiency such as slow speech, lack of energy, weight gain, hair loss, dry skin, and feeling cold. It also helps to treat goiter. It is also used to treat some kinds of thyroid cancer along with surgery and other medicines. Both synthetic and animal-derived thyroid tablets are available and can be prescribed for patients in need of additional thyroid hormone. Thyroid hormone is taken daily, and doctors can monitor blood levels to help assure proper dosing. Levothyroxine, the generic form of synthroid, is best taken 30–60 minutes before breakfast, as some food can diminish absorption. Calcium can inhibit the absorption of levothryoxine. Compared to water, coffee reduces absorption of levothyroxine by about 30 percent. Some patients might appear to be resistant to levothyroxine, when in fact they do not properly absorb the tablets – a problem which is solved by pulverizing the medication. There are several different treatment protocols in thyroid-replacement therapy:

T4 only
This treatment involves supplementation of levothyroxine alone, in a synthetic form. It is currently the standard treatment in mainstream medicine.
T4 and T3 in combination
This treatment protocol involves administering both synthetic L-T4 and L-T3 simultaneously in combination.
Desiccated thyroid extract
Desiccated thyroid extract is an animal-based thyroid extract, most commonly from a porcine source. It is also a combination therapy, containing natural forms of L-T4 and L-T3, as well as L-T1 and L-T2, which are not present in synthetic hormone medication.

Treatment controversy

The potential benefit from substituting some T3 for T4 has been investigated, but no conclusive benefit for combination therapy has been shown.

The 2002 Laboratory Medicine Practice Guidelines of the National Academy of Clinical Biochemistry state that during pregnancy, "The L-T4 dose should be increased (usually by 50 mcg/day) to maintain a serum TSH between 0.5 and 2.0 mIU/L and a serum FT4 in the upper third of the normal reference interval." Doctors however often assume that if your TSH is in the "normal range", sometimes defined as high as 5.5 mIu/L, it has no effect on fertility. Healthy pregnant women however have a TSH level of around 1.0 mIU/L.

Subclinical hypothyroidism

There is a range of opinion on the biochemical and symptomatic point at which to treat with levothyroxine, the typical treatment for overt hypothyroidism. Reference ranges have been debated as well. As of 2003, the American Association of Clinical Endocrinologists (ACEE) considers 0.3–3.0 mIU/L within normal range.

There is always the risk of overtreatment and hyperthyroidism. Some studies have suggested that subclinical hypothyroidism does not need to be treated. A 2007 meta-analysis by the Cochrane Collaboration found no benefit of thyroid-hormone replacement except "some parameters of lipid profiles and left-ventricular function." A 2002 meta-analysis looking into whether subclinical hypothyroidism may increase the risk of cardiovascular disease, as has been previously suggested, found a possible modest increase and suggested further studies be undertaken with coronary-heart disease as an end point "before current recommendations are updated."

Alternative treatments

Compounded slow-release T3 has been suggested for use in combination with T4, which proponents argue will mitigate many of the symptoms of functional hypothyroidism and improve quality of life. This is still controversial and is rejected by the conventional medical establishment.

Non-human presentation

Hypothyroidism is also a relatively common disease in domestic dogs, with some specific breeds having a definite predisposition.

See also

References

  1. "100,000 Older People Missing Thyroid Treatment – Study". BBC News. 2011-01-24.
  2. Simon H (2006-04-19). "Hypothyroidism". University of Maryland Medical Center. Retrieved 2008-02-28.
  3. Department of Pathology (June 13, 2005). "Pituitary Gland – Diseases/Syndromes". Virginia Commonwealth University (VCU). Archived from the original on 2008-02-06. Retrieved 2008-02-28.
  4. ^ ATA 2003, p. 6
  5. ^ Agabegi, Elizabeth D; Agabegi, Steven S. (2008). Step-Up to Medicine. Step-Up. Hagerstwon MD: Lippincott Williams & Wilkins. p. 160. ISBN 0-7817-7153-6.
  6. Burness, Christine E.; Shaw, Pamela J. (2008). "Thyroid Disease and the Nervous System". In Aminoff, Michael Jeffrey (ed.). Neurology and General Medicine. Churchill Livingstone. pp. 357–81. ISBN 978-0-443-06707-5. {{cite book}}: External link in |chapterurl= (help); Unknown parameter |chapterurl= ignored (|chapter-url= suggested) (help)
  7. ATA 2003, p. 4
  8. MedlinePlus Encyclopedia: Hypothyroidism – primary – see list of Symptoms
  9. "Hypothyroidism – In-Depth Report". New York Times. 2008. Retrieved 2012-06-18.
  10. "Hypothyroidism" (PDF). American Association of Clinical Endocrinologists.
  11. Yeum, C; Kim, SW; Kim, NH; Choi, KC; Lee, J (2002). "Increased expression of aquaporin water channels in hypothyroid rat kidney". Pharmacological Research. 46 (1): 85–8. doi:10.1016/S1043-6618(02)00036-1. PMID 12208125.
  12. "Thyroid and Weight" (PDF). The American Thyroid Association. Retrieved 2012-06-18.
  13. ^ Hypothyroidism fact sheet CDC medical records on VoxHealth. Retrieved on 2013-01-01
  14. Samuels, Mary H (2008). "Cognitive function in untreated hypothyroidism and hyperthyroidism". Current Opinion in Endocrinology, Diabetes and Obesity. 15 (5): 429–33. doi:10.1097/MED.0b013e32830eb84c. PMID 18769215.
  15. Rubin, Devon I; Aminoff, Michael J; Ross, Douglas S; Wilterdink, Janet L (November 12, 2009). "Neurologic manifestations of hypothyroidism".
  16. Hofeldt FD, Dippe S, Forsham PH (1972). "Diagnosis and classification of reactive hypoglycemia based on hormonal changes in response to oral and intravenous glucose administration" (PDF). Am. J. Clin. Nutr. 25 (11): 1193–201. PMID 5086042.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  17. Jabbar, A; Yawar, A; Waseem, S; Islam, N; Ul Haque, N; Zuberi, L; Khan, A; Akhter, J (2008). "Vitamin B12 deficiency common in primary hypothyroidism". JPMA. the Journal of the Pakistan Medical Association. 58 (5): 258–61. PMID 18655403.
  18. Lavalle, James B. Cracking the Metabolic Code. Vol. 1. p. 100. ISBN 1-4429-5039-0.
  19. Velázquez, E. M.; Arata, G. Bellabarba (1997). "Effects of Thyroid Status on Pituitary Gonadotropin and Testicular Reserve in Men". Systems Biology in Reproductive Medicine. 38: 85–92. doi:10.3109/01485019708988535.
  20. Clinical Medicine by Kumar and Clark, "Thyroid Axis Endocrinology," p. 610.
  21. American College of Psychiatrists 2010 PRITE (Psychiatry Resident In-Training Exam) question 38.
  22. Jack DeRuiter (2002). "Thyroid pathology". Endocrine Module (PYPP 5260). Auburn University School of Pharmacy. p. 30. {{cite book}}: |format= requires |url= (help); External link in |chapterurl= (help); Unknown parameter |chapterurl= ignored (|chapter-url= suggested) (help)
  23. The Royal College of Physicians, The Association for Clinical Biochemistry The Society for Endocrinology, The British Thyroid Association; et al. (19th November 2008). "The Diagnosis and Management of Primary Hypothyroidism" (pdf). Retrieved 2013-06-16. {{cite web}}: Check date values in: |date= (help); Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  24. Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1093/humupd/dmr024, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.1093/humupd/dmr024 instead.
  25. Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1093/humupd/dms052, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.1093/humupd/dms052 instead.
  26. ^ Chakera, AJ; Pearce, SH; Vaidya, B (2012). "Treatment for primary hypothyroidism: current approaches and future possibilities". Drug design, development and therapy. 6: 1–11. doi:10.2147/DDDT.S12894. PMID 22291465. {{cite journal}}: Cite has empty unknown parameter: |month= (help)CS1 maint: unflagged free DOI (link)
  27. Hollowell JG, Staehling NW, Flanders WD; et al. (2002). "Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)". J. Clin. Endocrinol. Metab. 87 (2): 489–99. PMID 11836274. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  28. Vanderpump, MP; Tunbridge, WM; French, JM; Appleton, D; Bates, D; Clark, F; Grimley Evans, J; Hasan, DM; Rodgers, H (1995). "The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey". Clinical endocrinology. 43 (1): 55–68. doi:10.1111/j.1365-2265.1995.tb01894.x. PMID 7641412.
  29. Fatourechi, V. (2009). "Subclinical Hypothyroidism: An Update for Primary Care Physicians". Mayo Clinic Proceedings. 84 (1): 65–71. doi:10.4065/84.1.65. PMC 2664572. PMID 19121255.
  30. Gaberscek, S; Zaletel, K (2011). "Thyroid physiology and autoimmunity in pregnancy and after delivery". Expert review of clinical immunology. 7 (5): 697–706. doi:10.1586/eci.11.42. PMID 21895480. {{cite journal}}: Unknown parameter |month= ignored (help)
  31. Offermanns, Stefan; Rosenthal, Walter (2008). Encyclopedia of Molecular Pharmacology, Volume 1 (2nd ed.). Springer. p. 189. ISBN 978-3-540-38916-3.
  32. Rivkees, SA (2010). "Pediatric Graves' disease: controversies in management". Hormones research in pediatrics. 74 (5): 305–311. doi:10.1159/000320028. PMID 20924158.
  33. Sharma, M; Aronow, WS; Patel, L; Gandhi, K; Desai, H (2011). "Hyperthyroidism". Medical science monitor. 17 (4): RA85 – RA91. doi:10.12659/MSM.881705. PMID 21455118. {{cite journal}}: Unknown parameter |month= ignored (help)
  34. Thyroiditis from Columbia University Medical Center, Department of Surgery, New York, NY. Retrieved Mars 2011
  35. Lazarus JH, Parkes AB, Premawardhana LD (2002). "Postpartum thyroiditis". Autoimmunity. 35 (3): 169–73. PMID 12389641. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  36. Rettori, V.; Jurcovicova, J.; McCann, S. M. (1987). "Central action of interleukin-1 in altering the release of tsh, growth hormone, and prolactin in the male rat". Journal of Neuroscience Research. 18 (1): 179–83. doi:10.1002/jnr.490180125. PMID 3500324.
  37. Sapolsky, R. M.; Krey, L. C.; McEwen, B. S. (1986). "The Neuroendocrinology of Stress and Aging: The Glucocorticoid Cascade Hypothesis". Endocrine Reviews. 7 (3): 284–301. doi:10.1210/edrv-7-3-284. PMID 3527687.
  38. Ongphiphadhanakul, B; Fang, SL; Tang, KT; Patwardhan, NA; Braverman, LE (1994). "Tumor necrosis factor-alpha decreases thyrotropin-induced 5'-deiodinase activity in FRTL-5 thyroid cells". European journal of endocrinology. 130 (5): 502–7. doi:10.1530/eje.0.1300502. PMID 8180680.
  39. Guhad, FA; Hau, J (1996). "Salivary IgA as a marker of social stress in rats". Neuroscience letters. 216 (2): 137–40. doi:10.1016/0304-3940(96)13037-8. PMID 8904802.
  40. Kimura, Hiroaki; Caturegli, Patrizio (2007). "Chemokine Orchestration of Autoimmune Thyroiditis". Thyroid. 17 (10): 1005–11. doi:10.1089/thy.2007.0267. PMID 17910527.
  41. Steingold KA, Matt DW, DeZiegler D, Sealey JE, Fratkin M, Reznikov S (1991). "Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure". J. Clin. Endocrinol. Metab. 73 (2): 275–80. doi:10.1210/jcem-73-2-275. PMID 1906893. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  42. Klecha, Alicia Juana; Barreiro Arcos, María Laura; Frick, Luciana; Genaro, Ana María; Cremaschi, Graciela (2008). "Immune-Endocrine Interactions in Autoimmune Thyroid Diseases". Neuroimmunomodulation. 15 (1): 68–75. doi:10.1159/000135626. PMID 18667802.
  43. Bauer, M; Priebe, S; Kürten, I; Gräf, KJ; Baumgartner, A (1994). "Psychological and endocrine abnormalities in refugees from East Germany: Part I. Prolonged stress, psychopathology, and hypothalamic-pituitary-thyroid axis activity". Psychiatry Research. 51 (1): 61–73. doi:10.1016/0165-1781(94)90047-7. PMID 8197271.
  44. Peeters RP, van der Geyten S, Wouters PJ; et al. (2005). "Tissue thyroid hormone levels in critical illness". J. Clin. Endocrinol. Metab. 90 (12): 6498–507. doi:10.1210/jc.2005-1013. PMID 16174716. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  45. Stouthard JM, van der Poll T, Endert E; et al. (1994). "Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans". J. Clin. Endocrinol. Metab. 79 (5): 1342–6. doi:10.1210/jc.79.5.1342. PMID 7962327. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  46. Abdullatif, HD; Ashraf, AP (2006). "Reversible subclinical hypothyroidism in the presence of adrenal insufficiency". Endocrine practice. 12 (5): 572. PMID 17002934.
  47. Allahabadia, A.; Razvi, S.; Abraham, P.; Franklyn, J. (2009). "Diagnosis and treatment of primary hypothyroidism". BMJ. 338: b725. doi:10.1136/bmj.b725. PMID 19325179.
  48. Baisier, W. V.; Hertoghe, J.; Eeckhaut, W. (2000). "Thyroid Insufficiency. Is TSH Measurement the Only Diagnostic Tool?". Journal of Nutritional and Environmental Medicine. 10 (2): 105–13. doi:10.1080/13590840050043521. {{cite journal}}: Unknown parameter |month= ignored (help)
  49. Nippoldt, Todd. "Hypothyroidism (underactive thyroid)". Maco Clinic. Retrieved 01/23/2012. {{cite web}}: Check date values in: |accessdate= (help)
  50. Benvenga, Salvatore; Bartolone, Luigi; Pappalardo, Maria Angela; Russo, Antonia; Lapa, Daniela; Giorgianni, Grazia; Saraceno, Giovanna; Trimarchi, Francesco (2008). "Altered Intestinal Absorption of L-Thyroxine Caused by Coffee". Thyroid. 18 (3): 293–301. doi:10.1089/thy.2007.0222. PMID 18341376.
  51. Yamamoto, Toshihide (2003). "Tablet Formulation of Levothyroxine Is Absorbed Less Well Than Powdered Levothyroxine". Thyroid. 13 (12): 1177–81. doi:10.1089/10507250360731596. PMID 14751040.
  52. American Association of Clinical Endocrinologists (2002). "Medical Guidelines For Clinical Practice For The Evaluation And Treatment Of Hyperthyroidism And Hypothyroidism" (PDF). Endocrine Practice. 8 (6): 457–69. PMID 15260011. {{cite journal}}: Unknown parameter |month= ignored (help)
  53. Bunevičius, Robertas; Kažanavičius, Gintautas; Žalinkevičius, Rimas; Prange, Arthur J. (1999). "Effects of Thyroxine as Compared with Thyroxine plus Triiodothyronine in Patients with Hypothyroidism". New England Journal of Medicine. 340 (6): 424–9. doi:10.1056/NEJM199902113400603. PMID 9971866. {{cite journal}}: Unknown parameter |month= ignored (help)
  54. Baisier, W. V.; Hertoghe, J.; Eeckhaut, W. (2001). "Thyroid Insufficiency. Is Thyroxine the Only Valuable Drug?". Journal of Nutritional and Environmental Medicine. 11 (3): 159–66. doi:10.1080/13590840120083376. {{cite journal}}: Unknown parameter |month= ignored (help)
  55. Escobar-Morreale, H. F.; Botella-Carretero, JI; Escobar Del Rey, F; Morreale De Escobar, G (2005). "Treatment of Hypothyroidism with Combinations of Levothyroxine plus Liothyronine". Journal of Clinical Endocrinology & Metabolism. 90 (8): 4946–54. doi:10.1210/jc.2005-0184. PMID 15928247.
  56. Joffe, R. T.; Brimacombe, M.; Levitt, A. J.; Stagnaro-Green, A. (2007). "Treatment of Clinical Hypothyroidism With Thyroxine and Triiodothyronine: A Literature Review and Metaanalysis". Psychosomatics. 48 (5): 379–84. doi:10.1176/appi.psy.48.5.379. PMID 17878495.
  57. "Subclinical Thyroid Disease" (PDF). Guidelines & Position Statements. The American Association of Clinical Endocrinologists. April 10, 2013. Retrieved 2008-06-08.
  58. Villar, Heloisa Cerqueira Cesar Esteves; Saconato, Humberto; Valente, Orsine; Atallah, Álvaro N (2007). Villar, Heloisa Cerqueira Cesar Esteves (ed.). "Cochrane Database of Systematic Reviews". Cochrane database of systematic reviews (Online) (3): CD003419. doi:10.1002/14651858.CD003419.pub2. PMID 17636722. {{cite journal}}: |chapter= ignored (help)
  59. Biondi B, Palmieri EA, Lombardi G, Fazio S (2002). "Effects of subclinical thyroid dysfunction on the heart". Ann. Intern. Med. 137 (11): 904–14. PMID 12458990. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  60. Ochs N; Auer R; Bauer DC; et al. (2008). "Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality". Ann. Intern. Med. 148 (11): 832–45. PMID 18490668. {{cite journal}}: Unknown parameter |author-separator= ignored (help); Unknown parameter |month= ignored (help)
  61. Todd, C H (2010). "Management of thyroid disorders in primary care: challenges and controversies". Postgraduate Medical Journal. 85 (1010): 655–9. doi:10.1136/pgmj.2008.077701. PMID 20075403.
  62. Brooks W (01/06/2008). "Hypothyroidism in Dogs". The Pet Health Library. VetinaryPartner.com. Retrieved 2008-02-28. {{cite web}}: Check date values in: |date= (help)

Further reading

External links

This template is no longer used; please see Template:Endocrine pathology for a suitable replacement

Template:Link GA

Categories: